INHIBITION OF FLT3 SIGNALING BOTH IN VITRO AND IN VIVO BY AC220, A SECOND GENERATION POTENT AND SELECTIVE FLT3 INHIBITOR

被引：0
|
作者：
Armstrong, R. [1 ]
Gunawardane, R. [1 ]
Rooks, A. [1 ]
Dao, A. [1 ]
Ricono, J. [1 ]
Brigham, D. [1 ]
Zarrinkar, P. [1 ]
Belli, B. [1 ]
Wierenga, W. [1 ]
机构：
[1] Ambit Biosci, San Diego, CA USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [41] Discovery of LDD-1075 as a potent FLT3 inhibitor
    Yoon, K. B.
    Lee, H. J.
    Han, S.
    FEBS OPEN BIO, 2019, 9 : 334 - 334
  • [42] FLT3 Inhibitor Treatment Increases FLT3 Expression That Exposes FLT3-ITD+ AML Blasts to Elimination By FLT3 CAR-T Cells
    Jetani, Hardikkumar
    Garcia-Cadenas, Irene
    Nerreter, Thomas
    Goetz, Ralph
    Sierra, Jorge
    Bonig, Halvard
    Sauer, Markus
    Einsele, Hermann
    Hudecek, Michael
    BLOOD, 2018, 132
  • [43] Discovery of LDD-1075 as a potent FLT3 inhibitor
    Yoon, Kyoung Bin
    Lee, Hyo Jeong
    Chung, Hye Jin
    Lee, Jungeun
    Choi, Jungil
    Heo, Jeong Doo
    Kim, Yong-Chul
    Han, Sun-Young
    ONCOLOGY LETTERS, 2019, 17 (05) : 4735 - 4741
  • [44] SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
    O'Farrell, AM
    Abrams, TJ
    Yuen, HA
    Ngai, TJ
    Louie, SG
    Yee, KWH
    Wong, LM
    Hong, W
    Lee, LB
    Town, A
    Smolich, BD
    Manning, WC
    Murray, LJ
    Heinrich, MC
    Cherrington, JM
    BLOOD, 2003, 101 (09) : 3597 - 3605
  • [45] Quizartinib, the Next FLT3 Inhibitor
    Cortes, Jorge
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (05) : 240 - 243
  • [46] In vivo effects of flt3 ligand
    Williams, DE
    BLOOD, 1997, 90 (12) : 5022 - 5022
  • [47] Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells
    Chen, Fangli
    Ishikawa, Yuichi
    Akashi, Akimi
    Naoe, Tomoki
    Kiyoi, Hitoshi
    ONCOTARGET, 2016, 7 (30) : 47018 - 47032
  • [48] Tyrosine phosphoproteomics of FLT3 signaling
    Gu, T
    Nardone, J
    Lee, K
    Gygi, S
    Rush, J
    Comb, M
    Polakiewicz, R
    BLOOD, 2005, 106 (11) : 357A - 357A
  • [49] NMS-03592088, a novel, potent FLT3, KIT and CSF1R inhibitor with activity in FLT3 positive acute myeloid leukemia patients with prior FLT3 inhibitor experience
    Curti, Antonio
    Rambaldi, Alessandro
    Cattaneo, Chiara
    Cairoli, Roberto
    Della Porta, Matteo
    Chiusolo, Patrizia
    Lussana, Federico
    Ubezio, Marta
    Mancini, Valentina
    Cano, Isabel
    Besliu, Carmen
    Claussen, Christian Hove
    Gatto, Rosalinda
    Crivori, Patrizia
    Colajori, Elena
    Somaschini, Alessio
    Davite, Cristina
    Isacchi, Antonella
    Ardini, Elena
    Mahnke, Lisa
    Montesinos, Pau
    CANCER RESEARCH, 2023, 83 (08)
  • [50] Discovery of a highly potent FLT3 kinase inhibitor for FLT3-ITD-positive AML
    Wu, H.
    Wang, A.
    Qi, Z.
    Li, X.
    Chen, C.
    Yu, K.
    Zou, F.
    Hu, C.
    Wang, W.
    Zhao, Z.
    Wu, J.
    Liu, J.
    Liu, X.
    Wang, L.
    Wang, W.
    Zhang, S.
    Stone, R. M.
    Galinsky, I. A.
    Griffin, J. D.
    Weinstock, D.
    Christodoulou, A.
    Wang, H.
    Shen, Y.
    Zhai, Z.
    Weisberg, E. L.
    Liu, J.
    Liu, Q.
    LEUKEMIA, 2016, 30 (10) : 2112 - 2116
12345